Skip Navigation LinksHome > September 2010 - Volume 16 - Issue 5 > Acute exacerbations of interstitial lung diseases
Current Opinion in Pulmonary Medicine:
doi: 10.1097/MCP.0b013e32833ae49d
Sarcoidosis: Edited by Om P. Sharma

Acute exacerbations of interstitial lung diseases

Papanikolaou, Ilias C; Drakopanagiotakis, Fotios; Polychronopoulos, Vlasis S

Collapse Box


Purpose of review: This review aims to highlight recent advances in pathogenesis, clinical presentation and treatment of interstitial lung diseases (ILDs).

Recent findings: Acute exacerbation is increasingly recognized as a major complication in the course of idiopathic pulmonary fibrosis. It is precipitated by a variety of intrinsic and extrinsic factors. Moreover, acute exacerbation is an apparently equally frequent event in hypersensitivity pneumonitis and collagen–vascular diseases associated ILDs, especially the rheumatoid pulmonary fibrosis. Treatment of acute exacerbations is unsatisfactory and prognosis extremely poor.

Summary: In a critically ill patient proper recognition of an acute exacerbation and of the underlying chronic ILD is warranted because treatment approach varies with the type of ILD. Advances in the understanding of the pathogenesis and treatment of this ‘idiopathic’ phenomenon are reviewed.

© 2010 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.